IDSA Home

What's New

Update Alert: Histoplasmosis

IDSA has updated its guideline on histoplasmosis, with four new recommendations for treating asymptomatic histoplasmomas and mild to moderate acute pulmonary histoplasmosis in adults, children, and pregnant individuals. The guideline excludes newborns and those with African or ocular histoplasmosis.

Statement on CDC Decision to Study Vaccines and Autism

Vaccines have been thoroughly researched and administered to large numbers of people of all ages and have been proven to be very safe and effective in preventing the spread of many serious infectious diseases and dramatically reducing deaths.

IDSA and HIVMA Join Rally to Protect Science & Public Health

The Infectious Diseases Society of America and the HIV Medicine Association will be Standing Up for Science at a rally March 7, 12–4 p.m. ET, in Washington, D.C., and we encourage members to participate in rallies planned in more than 30 cities around the United States.

IDSA & HIVMA Raise Alarm About Access to HIV Care Following USAID, PEPFAR Cuts

IDSA and HIVMA are deeply concerned by the abrupt cancellation of 92% of U.S. Agency for International Development foreign assistance awards and the impact the action will have on many, including the more than 20 million people to whom our country has made a commitment to provide access to HIV treatment through the President’s Emergency Plan for AIDS Relief.

Statement on Cancellation of FDA Vaccine Advisory Committee Meeting

Cancelling a critically important Food and Drug Administration meeting that is vital to the development of effective flu vaccines for next flu season is irresponsible, ignores science and shows a lack of concern for the protection of the public from this potentially severe disease. 

IDSA Virtual Member Forums

Please join IDSA and HIVMA for a series of virtual forums for members to connect with one another, strengthen community-building during a challenging political environment and hear updates from IDSA & HIVMA on policy and advocacy activities. During these forums, members of IDSA’s Public Policy and Advocacy Committee will facilitate a conversation about the new Administration’s actions affecting the infectious diseases community.